Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy

1969 Cancer Facts and Figures

1968 • 8,880 citations

Two pathogenetic types of endometrial carcinoma

1983 • 2,309 citations

Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study

1987 • 1,919 citations

Cancer statistics, 1995

1995 • 1,434 citations

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

1991 • 1,276 citations

Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *

1994 • 1,259 citations

The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients

1985 • 1,243 citations

Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer

1992 • 1,139 citations

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS

1989 • 932 citations

Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients.

1980 • 804 citations

Estrogens and Endometrial Cancer in a Retirement Community

1976 • 565 citations

After the Trial at Leicester

1981 • 545 citations

Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.

1988 • 420 citations

Endometrial Cancer and Estrogen Use

1979 • 392 citations

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.

1993 • 347 citations

Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast Cancer

1990 • 292 citations

CARDIAC NERVE LESIONS IN CHAGAS' DISEASE

1965 • 264 citations

Progestational Agents in the Treatment of Carcinoma of the Endometrium

1961 • 255 citations

TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM

1989 • 252 citations

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

1991 • 250 citations

Overexpression and mutation of p53 in endometrial carcinoma.

1992 • 227 citations

Precursors of Corpus Carcinoma Estrogens and Adenomatous Hyperplasia

1947 • 226 citations

Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor

1975 • 186 citations

Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma

1985 • 182 citations

High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.

1996 • 176 citations

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study

1990 • 172 citations

A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.

1994 • 170 citations

Tamoxifen Use in Breast Cancer Patients Who Subsequently Develop Corpus Cancer Is Not Associated with a Higher Incidence of Adverse Histologic Features

1994 • 163 citations

Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.

1993 • 153 citations

Prognostic significance of hormone receptors in endometrial cancer

1993 • 151 citations

Endometrial Cancer in Relation to Patterns of Menopausal Estrogen Use

1979 • 140 citations

Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients

1981 • 138 citations

Tamoxifen in premenopausal patients with metastatic breast cancer: a review.

1991 • 122 citations

Progestin Therapy of Endometrial, Breast and Ovarian Carcinoma

1984 • 118 citations

Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: A preliminary report

1990 • 114 citations

Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer Patients

1994 • 108 citations

Endometrial adenocarcinoma in stein-leventhal syndrome

1974 • 107 citations

Proliferative endometrial response to theca-granulosa cell tumors

1971 • 105 citations

Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia

1985 • 98 citations

Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy.

1992 • 97 citations

Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies

1990 • 92 citations

The treatment of advanced endometrial cancer with hydroxyprogesterone caproate

1974 • 91 citations

Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer—Preliminary report

1991 • 89 citations

Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: An important prognostic indicator

1989 • 76 citations

Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium.

1992 • 72 citations

Flow cytometric DNA analysis of stage I endometrial carcinoma

1989 • 72 citations

Carcinogenic Effects of Adjuvant Tamoxifen Treatment and Radiotherapy for Early Breast Cancer

1992 • 67 citations

Tamoxifen and endometrial cancer

1996 • 62 citations

Multidrug treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

1984 • 56 citations

Chemotherapy of metastatic endometrial cancer.

1994 • 46 citations

Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status

1988 • 39 citations

Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.

1984 • 37 citations

Screening techniques in endometrial cancer

1976 • 36 citations

The use of megestrol acetate in the treatment of advanced malignant lesions of the endometrium

1973 • 36 citations

Endometrial cancer: prognostic factors.

1994 • 36 citations

Nonhormonal chemotherapy of endometrial adenocarcinoma: A review

1974 • 36 citations

Histologic screening for endometrial cancer

1974 • 29 citations

Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment.

1986 • 26 citations

Expression of MIB-1 (Paraffin ki-67) and AgNOR Morphology in Endometrial Adenocarcinomas of Endometrioid Type

1994 • 24 citations

Treatment of advanced or recurrent endometrial carcinoma with medroxyprogesterone acetate (MPA): A gynecologic oncology group study

1985 • 23 citations

Tamoxifen and the gynaecologist

1993 • 23 citations

Diagnostic outpatient aspiration curettage.

1975 • 21 citations

Surgical pathological staging of endometrial carcinoma and results of treatment.

1992 • 20 citations

Serial CA 125 Levels During Chemotherapy for Metastatic or Recurrent Endometrial Cancer

1991 • 20 citations

Tamoxifen-induced increase in cytosol progestin receptor levels in a case of metastatic endometrial cancer

1983 • 18 citations

Serial CA 125 levels during chemotherapy for metastatic or recurrent endométrial cancer

1992 • 18 citations

Virulence factors in endometrial cancer

1993 • 16 citations